|
1
|
Rubini Gimenez M, Thiele H and Pöss J:
Management of acute coronary syndrome without ST-segment elevation.
Herz. 47:381–392. 2022.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
2
|
Hjort M, Eggers KM, Lindhagen L, Baron T,
Erlinge D, Jernberg T, Marko-Varga G, Rezeli M, Spaak J and Lindahl
B: Differences in biomarker concentrations and predictions of
long-term outcome in patients with ST-elevation and
non-ST-elevation myocardial infarction. Clin Biochem. 98:17–23.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Braunwald E and Morrow DA: Unstable
angina: Is it time for a requiem? Circulation. 127:2452–2457.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ibanez B, James S, Agewall S, Antunes MJ,
Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA,
Halvorsen S, et al: 2017 ESC Guidelines for the management of acute
myocardial infarction in patients presenting with ST-segment
elevation: The Task Force for the management of acute myocardial
infarction in patients presenting with ST-segment elevation of the
European society of cardiology (ESC). Eur Heart J. 39:119–177.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sandeman D, Syed MBJ, Kimenai DM, Lee KK,
Anand A, Joshi SS, Dinnel L, Wenham PR, Campbell K, Jarvie M, et
al: Implementation of an early rule-out pathway for myocardial
infarction using a high-sensitivity cardiac troponin T assay. Open
Heart. 8(e001769)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ishak M, Ali D, Fokkert MJ, Slingerland
RJ, Dikkeschei B, Tolsma RT, Lichtveld RA, Bruins W, Boomars R,
Bruheim K, et al: Fast assessment and management of chest pain
without ST-elevation in the pre-hospital gateway: rationale and
design. Eur Heart J Acute Cardiovasc Care. 4:129–136.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Giannitsis E, Garfias-Veitl T, Slagman A,
Searle J, Müller C, Blankenberg S, von Haehling S, Katus HA, Hamm
CW, Huber K, et al: Biomarkers-in-cardiology 8
RE-VISITED-consistent safety of early discharge with a dual marker
strategy combining a normal hs-cTnT with a normal copeptin in
low-to-intermediate risk patients with suspected acute coronary
syndrome-A secondary analysis of the randomized
biomarkers-in-cardiology 8 trial. Cells. 11(211)2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
O'Donoghue M, Morrow DA, Sabatine MS,
Murphy SA, McCabe CH, Cannon CP and Braunwald E:
Lipoprotein-associated phospholipase A2 and its association with
cardiovascular outcomes in patients with acute coronary syndromes
in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin evaluation and
infection therapy-thrombolysis in myocardial infarction) trial.
Circulation. 113:1745–1752. 2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Inoue K, Chieh JTW, Yeh LC, Chiang SJ,
Phrommintikul A, Suwanasom P, Kasim S, Ahmad B, Idrose AM, Salleh
FM, et al: An international, stepped wedge, cluster-randomized
trial investigating the 0/1-h algorithm in suspected acute coronary
syndrome in Asia: The rational of the DROP-Asian ACS study. Trials.
23(986)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Möckel M, Danne O, Müller R, Vollert JO,
Müller C, Lueders C, Störk T, Frei U, Koenig W, Dietz R and Jaffe
AS: Development of an optimized multimarker strategy for early risk
assessment of patients with acute coronary syndromes. Clin Chim
Acta. 393:103–109. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Morawiec B, Kawecki D, Przywara-Chowaniec
B, Opara M, Muzyk P, Ho L, Tat LC, Gabrysiak A, Muller O and
Nowalany-Kozielska E: Copeptin as a prognostic marker in acute
chest pain and suspected acute coronary syndrome. Dis Markers.
2018(6597387)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Möckel M, Müller R, Vollert J, Müller C,
Danne O, Gareis R, Störk T, Dietz R and Koenig W:
Lipoprotein-associated phospholipase A2 for early risk
stratification in patients with suspected acute coronary syndrome:
A multi-marker approach: The North Wuerttemberg and Berlin
infarction study-II (NOBIS-II). Clin Res Cardiol. 96:604–612.
2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
van Cauteren YJM, Smulders MW, Theunissen
RALJ, Gerretsen SC, Adriaans BP, Bijvoet GP, Mingels AMA, van Kuijk
SMJ, Schalla S, Crijns HJGM, et al: Cardiovascular magnetic
resonance accurately detects obstructive coronary artery disease in
suspected non-ST elevation myocardial infarction: A sub-analysis of
the CARMENTA trial. J Cardiovasc Magn Reson. 23(40)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Dhillon OS, Narayan HK, Khan SQ, Kelly D,
Quinn PA, Squire IB, Davies JE and Ng LL: Pre-discharge risk
stratification in unselected STEMI: is there a role for ST2 or its
natural ligand IL-33 when compared with contemporary risk markers?
Int J Cardiol. 167:2182–2188. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kohli P, Bonaca MP, Kakkar R, Kudinova AY,
Scirica BM, Sabatine MS, Murphy SA, Braunwald E, Lee RT and Morrow
DA: Role of ST2 in non-ST-elevation acute coronary syndrome in the
MERLIN-TIMI 36 trial. Clin Chem. 58:257–266. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sabatine MS, Morrow DA, Higgins LJ,
MacGillivray C, Guo W, Bode C, Rifai N, Cannon CP, Gerszten RE and
Lee RT: Complementary roles for biomarkers of biomechanical strain
ST2 and N-terminal prohormone B-type natriuretic peptide in
patients with ST-elevation myocardial infarction. Circulation.
117:1936–1944. 2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dohi T, Miyauchi K, Okazaki S, Yokoyama T,
Ohkawa R, Nakamura K, Yanagisawa N, Tsuboi S, Ogita M, Yokoyama K,
et al: Decreased circulating lipoprotein-associated phospholipase
A2 levels are associated with coronary plaque regression in
patients with acute coronary syndrome. Atherosclerosis.
219:907–912. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Januzzi JL Jr: ST2 as a cardiovascular
risk biomarker: From the bench to the bedside. J Cardiovasc Transl
Res. 6:493–500. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang J, Tan GJ, Han LN, Bai YY, He M and
Liu HB: Novel biomarkers for cardiovascular risk prediction. J
Geriatr Cardiol. 14:135–150. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
McDonagh TA, Metra M, Adamo M, Gardner RS,
Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et
al: 2021 ESC guidelines for the diagnosis and treatment of acute
and chronic heart failure. Eur Heart J. 42:3599–3726.
2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Visseren FLJ, Mach F, Smulders YM,
Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM,
Capodanno D, et al: 2021 ESC guidelines on cardiovascular disease
prevention in clinical practice: Developed by the Task Force for
cardiovascular disease prevention in clinical practice with
representatives of the European society of cardiology and 12
medical societies with the special contribution of the European
association of preventive cardiology (EAPC). Rev Esp Cardiol (Engl
Ed). 75(429)2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lapostolle F, Loyeau A, Bataille S, Boche
T, Le Bail G, Weisslinger L, Juliard JM and Lambert Y: New European
society of cardiology guidelines for the management of patients
with ST-elevation myocardial infarction: Effect on physician's
compliance and patient's outcome. Eur J Emerg Med. 26:380–381.
2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
DeLong ER, DeLong DM and Clarke-Pearson
DL: Comparing the areas under two or more correlated receiver
operating characteristic curves: A nonparametric approach.
Biometrics. 44:837–845. 1988.PubMed/NCBI
|
|
24
|
Du X, Patel A, Anderson CS, Dong J and Ma
C: Epidemiology of cardiovascular disease in China and
opportunities for improvement: JACC international. J Am Coll
Cardiol. 73:3135–3147. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Dalal JJ, Ponde CK, Pinto B, Srinivas CN,
Thomas J, Modi SK, Mehta S, Shetty S, Manimarane and Desai
B: Time to shift from contemporary to high-sensitivity cardiac
troponin in diagnosis of acute coronary syndromes. Indian Heart J.
68:851–855. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Duraes AR, Bitar YS, Freitas ACT, Filho
IM, Freitas BC and Fernandez AM: Gender differences in ST-elevation
myocardial infarction (STEMI) time delays: Experience of a public
health service in Salvador-Brazil. Am J Cardiovasc Dis. 7:102–107.
2017.PubMed/NCBI
|
|
27
|
Kuehnemund L, Koeppe J, Feld J, Wiederhold
A, Illner J, Makowski L, Gerß J, Reinecke H and Freisinger E:
Gender differences in acute myocardial infarction-A nationwide
German real-life analysis from 2014 to 2017. Clin Cardiol.
44:890–898. 2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Akbar H and Mountfort S: Acute ST-segment
elevation myocardial infarction (STEMI). In: StatPearls. StatPearls
Publishing LLC. Treasure Island, FL, 2025.
|
|
29
|
Al-Assadi MY, Aljaber NN, Al-Habeet A, Al
Nono O and Al-Motarreb A: Sex-related differences in acute coronary
syndrome: Insights from an observational study in a Yemeni cohort.
Front Cardiovasc Med. 12(1481917)2025.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Soeiro AM, Silva PGMBE, Roque EAC, Bossa
AS, Biselli B, Leal TCAT, Soeiro MCFA, Pitta FG, Serrano CV Jr and
Oliveira MT Jr: Prognostic differences between men and women with
acute coronary syndrome. Data from a Brazilian registry. Arq Bras
Cardiol. 111:648–653. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sári C, Heesch CM, Kovács AJ and Andréka
P: Sex-related differences in care and prognosis in acute coronary
syndrome. Prev Med Rep. 55(103131)2025.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kavsak PA, Shortt C, Ma J, Clayton N,
Sherbino J, Hill SA, McQueen M, Mehta SR, Devereaux PJ and Worster
A: A laboratory score at presentation to rule-out serious cardiac
outcomes or death in patients presenting with symptoms suggestive
of acute coronary syndrome. Clin Chim Acta. 469:69–74.
2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Aimo A, Januzzi JL Jr, Bayes-Genis A,
Vergaro G, Sciarrone P, Passino C and Emdin M: Clinical and
prognostic significance of sST2 in heart failure: JACC review topic
of the week. J Am Coll Cardiol. 74:2193–2203. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Sanada S, Hakuno D, Higgins LJ, Schreiter
ER, McKenzie AN and Lee RT: IL-33 and ST2 comprise a critical
biomechanically induced and cardioprotective signaling system. J
Clin Invest. 117:1538–1549. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
35
|
Stătescu C, Anghel L, Tudurachi BS, Leonte
A, Benchea LC and Sascău RA: From classic to modern prognostic
biomarkers in patients with acute myocardial infarction. Int J Mol
Sci. 23(9168)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Badimon L, Romero JC, Cubedo J and
Borrell-Pagès M: Circulating biomarkers. Thromb Res. 130 (Suppl
1):S12–S15. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Smulders MW, Kietselaer BLJH, Wildberger
JE, Dagnelie PC, Brunner-La Rocca HP, Mingels AMA, van Cauteren
YJM, Theunissen RALJ, Post MJ, Schalla S, et al: Initial
imaging-guided strategy versus routine care in patients with
non-ST-segment elevation myocardial infarction. J Am Coll Cardiol.
74:2466–2477. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhang H, Gao Y, Wu D and Zhang D: The
relationship of lipoprotein-associated phospholipase A2 activity
with the seriousness of coronary artery disease. BMC Cardiovasc
Disord. 20(296)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhao SQ, Chang H and Zhang L: Correlation
between the level of lipoprotein-associated phospholipase A2
activity in serum, the degree of coronary artery ste-nosis and
major adverse cardiovascular events in patients with coronary heart
disease. Chin J Lab Diagn. 1:1621–1624. 2021.
|
|
40
|
Verdoia M, Rolla R, Gioscia R, Rognoni A
and De Luca G: Novara Atherosclerosis Study Group (NAS).
Lipoprotein associated-phospholipase A2 in STEMI vs NSTE-ACS
patients: a marker of cardiovascular atherosclerotic risk rather
than thrombosis. J Thromb Thrombolysis. 56:37–44. 2023.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Chung H, Kwon HM, Kim JY, Yoon YW, Rhee J,
Choi EY, Min PK, Hong BK, Rim SJ, Yoon JH, et al:
Lipoprotein-associated phospholipase A2 is related to
plaque stability and is a potential biomarker for acute coronary
syndrome. Yonsei Med J. 55:1507–1515. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Gale CP, Stocken DD, Aktaa S, Reynolds C,
Gilberts R, Brieger D, Carruthers K, Chew DP, Goodman SG, Fernandez
C, et al: Effectiveness of GRACE risk score in patients admitted to
hospital with non-ST elevation acute coronary syndrome (UKGRIS):
Parallel group cluster randomised controlled trial. BMJ.
381(e073843)2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Neumann FJ and Sousa-Uva M: ‘Ten
commandments’ for the 2018 ESC/EACTS guidelines on myocardial
revascularization. Eur Heart J. 40:79–80. 2019.PubMed/NCBI View Article : Google Scholar
|
